Presenilin-1

Structure

Presenilin possesses a 9 transmembrane domain topology, with an extracellular C-terminus and a cytosolic N-terminus. Presenilin undergoes endo-proteolytic processing to produce ~27-28 kDa N-terminal and ~16-17 kDa C-terminal fragments in humans. Furthermore, presenilin exists in the cell mainly as a heterodimer of the C-terminal and N-terminus fragments. When presenilin 1 is overexpressed, the full length protein accumulates in an inactive form. Based on evidence that a gamma-secretase inhibitor binds to the fragments, the cleaved presenilin complex is considered to be the active form.

Function

Presenilins are postulated to regulate APP processing through their effects on gamma secretase, an enzyme that cleaves APP. Also, it is thought that the presenilins are involved in the cleavage of the Notch receptor, such that they either directly regulate gamma secretase activity or themselves are protease enzymes. Multiple alternatively spliced transcript variants have been identified for this gene, the full-length natures of only some have been determined.

Notch signaling pathway

In Notch signaling, critical proteolytic reactions takes place during maturation and activation of Notch membrane receptor. Notch1 is cleaved extracellularlly at site1 (S1) and two polypeptides are produced to form a heterodimer receptor on the cell surface. After the formation of receptor, Notch1 is further cleaved in site 3(S3) and release Notch1 intracellular domain (NICD) from the membrane.

Presenilin 1 has been shown to play an important role in proteolytic process. In the prenilin 1 null mutant drosophila, Notch signaling is abolished and it displays a notch-like lethal phenotype. Moreover, in mammalian cells, deficiency of PSEN1 also causes the defect in the proteolytic release of NICD from a truncated Notch construct. The same step can be also blocked by several gamma-secretase inhibitors, shown in the same study. These evidences collectively suggest a critical role of presenilin 1 in the Notch signaling pathway.

Wnt signaling pathway

Wnt signaling pathway has been shown to be involved in several critical steps in embryogenesis and development. Presenilin 1 has been shown to form a complex with beta-catenin, an important component in Wnt signaling, and stabilize beta-catenin. Mutant of presenilin-1 that reduces the ability to stabilize beta-catenin complex leads to hyperactive degradation of beta-catenin in the brains of transgenic mice.

Considered as a negative regulator in Wnt signaling pathway, presenilin-1 was also found to play a role in beta-catenin phosphorylation. Beta-catenin is coupled by presenilin-1 and undergoes a sequential phosphorylation by two kinase activities. The study also further illustrates that the deficiency of presenilin 1 disconnects the sequential phosphorylation and thus disrupts the normal wnt signaling pathway.

Clinical significance

Beta-amyloid production

Transgenic mice that over-expressed mutant presenilin-1 show an increase of beta-amyloid-42(43) in the brain, which suggest presenilin-1 plays an important role in beta-amyloid regulation and can be highly related to Alzheimer's disease. Further study conducted in neuronal cultures derived from presenilin-1 deficient mouse embryos showed that cleavage by alpha- and beta- secretase was still normal without the presence of presenilin-1. Meanwhile, when the cleavage by gamma-cleavage of the transmembrane domain of APP was abolished a 5-fold drop of amyloid peptide was observed, suggesting that deficiency of presenilin-1 can downregulate amyloid and inhibition of presenilin-1 can be a potential method for anti-amyloidogenic therapy in Alzheimer's disease. Extensive study on the role of presenilin-1 in amyloid production has been conducted to improve our understanding of Alzheimer's disease.

Alzheimer's disease

Alzheimer's disease (AD) patients with an inherited form of the disease may carry mutations in the presenilin proteins (PSEN1; PSEN2) or the amyloid precursor protein (APP). These disease-linked mutations result in increased production of the longer form of amyloid beta (main component of amyloid deposits found in AD brains). These mutations result in early-onset Alzheimer's Disease, which is a rare form of the disease. These rare genetic variants are autosomal dominant.

Cancer

In addition to its role in Alzheimer's disease, presenilin-1 also found to be important in cancer. A study of broad range gene expression was conducted on human melanoma. Researchers classified the melanoma cell lines into two types. The study showed that presenilin-1 is down regulated in this cell type while it is overexpressed in the other cell type. Another study on multidrug resistance (MDR) cell line also reveals a role of presenilin-1 in cancer development. Because of the development to the resistance to chemicals, MDR cells become a critical factor on the success of cancer chemotherapy. In the study, researchers tried to explore the molecular mechanism by looking into the expression of Notch1 intracellular (N1IC) domain and presenilin 1. They found that there is higher level expression of both proteins and a multidrug resistance-associated protein 1 (ABCC1) was also found to be regulated by N1IC, which suggest a mechanism of ABCC1 regulated by presenilin 1 and notch signaling.

Interactions

PSEN1 has been shown to interact with:

• BCL2,
• CTNNB1,
• CTNND1,
• FLNB,
• GFAP,
• Delta catenin,
• ICAM5,
• KCNIP3,
• NCSTN,
• PKP4, and
• UBQLN1.

References

References

1. (Nov 1992). "Genetic linkage evidence for a familial Alzheimer's seasesease locus on chromosome 14". Science.
2. (1994). "Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease". Annu. Rev. Cell Biol..
3. (October 2005). "A nine-transmembrane domain topology for presenilin 1". J. Biol. Chem..
4. (February 2008). "Building gamma-secretase: the bits and pieces". J. Cell Sci..
5. (July 1996). "Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo". Neuron.
6. (September 1997). "Endoproteolytic processing and stabilization of wild-type and mutant presenilin". J. Biol. Chem..
7. (June 2000). "Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1". Nature.
8. (May 2005). "Presenilin endoproteolysis is an intramolecular cleavage". Mol. Cell. Neurosci..
9. "Entrez Gene: PSEN1 presenilin 1 (Alzheimer disease 3)".
10. (August 1998). "Roles for proteolysis and trafficking in notch maturation and signal transduction". Cell.
11. (July 1998). "The Notch1 receptor is cleaved constitutively by a furin-like convertase". Proc. Natl. Acad. Sci. U.S.A..
12. (May 1998). "Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain". Nature.
13. (September 1995). "Signalling downstream of activated mammalian Notch". Nature.
14. (April 1999). "Presenilin is required for activity and nuclear access of Notch in Drosophila". Nature.
15. (April 1999). "A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain". Nature.
16. (July 2009). "Presenilins are essential for regulating neurotransmitter release". Nature.
17. (September 2002). "Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis". Cell.
18. (October 1996). "Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1". Nature.
19. (January 1998). "Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein". Nature.
20. (June 2004). "Presenilin 1 stabilizes the C-terminal fragment of the amyloid precursor protein independently of gamma-secretase activity". J. Biol. Chem..
21. (May 2003). "GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides". Nature.
22. (2012). "Epidemiology of Alzheimer disease". Cold Spring Harbor Perspectives in Medicine.
23. (May 2009). "Two types of human malignant melanoma cell lines revealed by expression patterns of mitochondrial and survival-apoptosis genes: implications for malignant melanoma therapy". Mol. Cancer Ther..
24. (January 2002). "Multidrug resistance in cancer: role of ATP-dependent transporters". Nat. Rev. Cancer.
25. (December 2011). "Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells". Proc. Natl. Acad. Sci. U.S.A..
26. (October 1999). "Presenilin 1 protein directly interacts with Bcl-2". J. Biol. Chem..
27. (December 1998). "Abrogation of the presenilin 1/beta-catenin interaction and preservation of the heterodimeric presenilin 1 complex following caspase activation". J. Biol. Chem..
28. (June 1999). "Presenilin 1 facilitates the constitutive turnover of beta-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin-signaling pathway". J. Neurosci..
29. (August 1998). "Direct association of presenilin-1 with beta-catenin". FEBS Lett..
30. (February 1999). "Isolation of human delta-catenin and its binding specificity with presenilin 1". NeuroReport.
31. (February 1998). "Interaction of presenilins with the filamin family of actin-binding proteins". J. Neurosci..
32. (August 2002). "A new splice variant of glial fibrillary acidic protein, GFAP epsilon, interacts with the presenilin proteins". J. Biol. Chem..
33. (1999). "Presenilins interact with armadillo proteins including neural-specific plakophilin-related protein and beta-catenin.". Journal of Neurochemistry.
34. (November 2001). "Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins". Neuron.
35. (October 1998). "Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment". Nat. Med..
36. (July 2000). "Isolation and characterization of novel presenilin binding protein". J. Neurochem..
37. (August 2004). "Nicalin and its binding partner Nomo are novel Nodal signaling antagonists". EMBO J..
38. (November 2003). "Functional gamma-secretase complex assembly in Golgi/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and gamma-secretase substrates". Neurobiol. Dis..
39. (February 2003). "APH-1 interacts with mature and immature forms of presenilins and nicastrin and may play a role in maturation of presenilin.nicastrin complexes". J. Biol. Chem..
40. (November 2002). "Mammalian APH-1 interacts with presenilin and nicastrin and is required for intramembrane proteolysis of amyloid-beta precursor protein and Notch". J. Biol. Chem..
41. (September 2000). "Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing". Nature.
42. (April 1999). "Direct interaction of Alzheimer's disease-related presenilin 1 with armadillo protein p0071". J. Biol. Chem..
43. (November 2000). "Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation". J. Cell Biol..